Reprocessing capabilities of newly approved devices for use in surgery

Area of Science:

• Medical device reprocessing
• Surgical device sustainability
• Healthcare environmental impact

Background:

• Single-use surgical devices contribute to environmental waste and increased healthcare costs.
• Reprocessing medical devices offers a potential solution for cost reduction and environmental impact mitigation.
• This study examines the reprocessing capabilities of novel surgical devices recently approved by the FDA.

Purpose of the Study:

• To investigate the reprocessing capabilities of newly FDA-approved surgical devices.
• To assess the availability of reprocessing for general, plastic, and electrosurgical devices.
• To compare the costs of single-use versus reprocessed surgical devices.

Main Methods:

• Surgical devices were identified from the FDA Releasable 510(k) Database (2018-2023).
• Devices were categorized by product codes for general/plastic surgery (GCJ) and electrosurgical (GEI) instruments.
• Data on device usage, reprocessing capabilities, and costs were extracted from public sources.

Main Results:

• Out of 658,510(k) applications, 3.8% were for surgical devices.
• Reprocessing capabilities were found in 29% of GCJ devices and 14% of GEI devices.
• Single-use GCJ and GEI devices were less expensive on average than their reprocessed counterparts ($11,314 vs $17,206 and $8,554 vs $16,134, respectively).

Conclusions:

• Reprocessing capabilities for new surgical devices are currently limited and variable.
• Enhancing the reprocessing potential of new surgical devices is crucial for wider adoption in surgical practices.
• Further research and development are needed to expand reprocessing options for surgical instruments.